'Extreme duplication' in the USFDA adverse events reporting system database

被引:62
作者
Reich, Lester
机构
[1] Pfrizer Inc, Risk Management Strategy, Safety & Risk Management, New York, NY 10017 USA
[2] NYU, Dept Med, Sch Med, New York, NY USA
[3] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA
[4] New York Med Coll, Dept Community & Prevent Med, Valhalla, NY 10595 USA
[5] Brunel Univ, Sch Informat Comp & Math, London, England
关键词
D O I
10.2165/00002018-200730060-00009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:551 / 554
页数:4
相关论文
共 7 条
[1]   Data mining in spontaneous reports [J].
Bate, A ;
Edwards, IR .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 98 (03) :324-330
[2]  
*CDER GUID, GUID IND GUID POSTM
[3]   Data mining in pharmacovigilance - The need for a balanced perspective [J].
Hauben, M ;
Patadia, V ;
Gerrits, C ;
Walsh, L ;
Reich, L .
DRUG SAFETY, 2005, 28 (10) :835-842
[4]   Communication of findings in pharmacovigilance: use of the term "signal" and the need for precision in its use [J].
Hauben, M ;
Reich, L .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (5-6) :479-480
[5]  
*LINC TECHN INC, 2005, PREP FOI DRUG SAF DA
[6]   Duplicate detection in adverse drug reaction surveillance [J].
Noren, G. Niklas ;
Orre, Roland ;
Bate, Andrew ;
Edwards, I. Ralph .
DATA MINING AND KNOWLEDGE DISCOVERY, 2007, 14 (03) :305-328
[7]   Evaluation of suspected adverse drug reactions - Reply [J].
Strom, BL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (11) :1324-1325